ABBV vs ZBH
By Alex · Tickerpine
AbbVie Inc. vs Zimmer Biomet Holdings, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | ZBH |
|---|---|---|
| Price | $295.03 | $103.21 |
| Market cap | $521.50B | $19.53B |
| P/E ratio | 50.7 | 26.1 |
| ROE | — | 6.03% |
| Profit margin | 15.67% | 8.95% |
| Revenue growth | 10.30% | 3.10% |
| Dividend yield | 2.35% | 0.93% |
| Beta | 0.19 | 0.47 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs ZBH in plain English
- ABBV is the bigger company — about 26.7× the market cap of ZBH.
- ZBH is cheaper on earnings (P/E 26.1 vs 50.7).
- ABBV is growing revenue faster (10% vs 3%).
- ABBV has the higher dividend yield (2.35% vs 0.93%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
ZBH return calculator
See what $1,000 in Zimmer Biomet Holdings, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.